Spark Investment Management’s Genesis Healthcare, Inc. GEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-11,479
Closed -$6K 67
2020
Q3
$6K Hold
11,479
0.01% 51
2020
Q2
$7K Hold
11,479
0.03% 85
2020
Q1
$9K Sell
11,479
-31,707
-73% -$45.3K ﹤0.01% 359
2019
Q4
$70K Buy
43,186
+6,486
+18% +$9.74K 0.01% 514
2019
Q3
$40K Hold
36,700
0.01% 377
2019
Q2
$45K Sell
36,700
-46,300
-56% -$58.9K ﹤0.01% 527
2019
Q1
$119K Buy
83,000
+13,200
+19% +$19.6K 0.01% 560
2018
Q4
$82K Buy
+69,800
New +$104K 0.01% 581
2018
Q3
Sell
-22,100
Closed -$50K 781
2018
Q2
$50K Buy
+22,100
New +$42.7K ﹤0.01% 637
2016
Q4
Sell
-61,400
Closed -$163K 932
2016
Q3
$163K Sell
61,400
-298,500
-83% -$686K 0.01% 698
2016
Q2
$637K Buy
359,900
+83,300
+30% +$170K 0.06% 410
2016
Q1
$641K Buy
276,600
+197,000
+247% +$446K 0.06% 387
2015
Q4
$276K Buy
+79,600
New +$381K 0.04% 497
2015
Q2
Sell
-66,500
Closed -$473K 775
2015
Q1
$473K Buy
+66,500
New +$502K 0.07% 383

Other funds holding GEN

Spark Investment Management's GEN Position: Q4 2020 in Review

Spark Investment Management sold out of Genesis Healthcare, Inc. (GEN) in Q4 2020, closing a stake of 11,479 shares — an estimated $6K sold.

Spark Investment Management first reported a position in GEN in Q1 2015 and held it in 14 quarters. The position peaked at $641K in Q1 2016. 49 funds tracked by Wall St. Rank hold GEN as of Q4 2020.

  • Spark Investment Management reported no remaining Genesis Healthcare, Inc. position as of Q4 2020 after selling out during the quarter.
  • Spark Investment Management sold 11,479 Genesis Healthcare, Inc. shares in Q4 2020, an estimated $6K.
  • Spark Investment Management first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 14 quarters.
  • Spark Investment Management's Genesis Healthcare, Inc. position peaked at $641K in Q1 2016.
  • 49 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q4 2020.

Based on Spark Investment Management's 13F filing for Q4 2020, filed 11 Feb 2021.